We are live on ! Find out more
BCMU

BlueCrest Capital Management (UK) Portfolio holdings

AUM $2.66B
1-Year Est. Return 11.87%
This Fund
S&P 500
This Quarter Est. Return
+4.51%
1 Year Est. Return
+11.87%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.77B
AUM Growth
+$555M
Cap. Flow
+$300M
Cap. Flow %
16.9%
Top 10 Hldgs %
27.58%
Holding
682
New
309
Increased
98
Reduced
45
Closed
186

Top Buys

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$27.3M
2
YELL
Yellow Corporation Common Stock
YELL
+$26M
3
MMM icon
3M
MMM
+$23.3M
4
DVN icon
Devon Energy
DVN
+$15.1M
5
HAL icon
Halliburton
HAL
+$11.8M

Sector Composition

Rank Sector Weight
1 Energy 13.66%
2 Industrials 8.4%
3 Financials 6.44%
4 Healthcare 3.95%
5 Consumer Discretionary 3.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCBK
426
DELISTED
HUDSON CITY BANCORP INC
HCBK
$197K 0.01%
+20,000
New +$187K
HRTX icon
427
Heron Therapeutics
HRTX
$94.5M
$192K 0.01%
+13,800
New +$184K
EXA
428
DELISTED
EXA Corporation
EXA
$191K 0.01%
+14,400
New +$204K
PGEM
429
DELISTED
Ply Gem Holdings, Inc.
PGEM
$189K 0.01%
+15,000
New +$201K
NNVC icon
430
NanoViricides
NNVC
$35.7M
$187K 0.01%
+2,920
New +$250K
BEAT
431
DELISTED
BioTelemetry, Inc.
BEAT
$186K 0.01%
+18,470
New +$170K
EXEL icon
432
CALL
Exelixis
EXEL
$13.1B
$177K 0.01%
+50,100
New +$341K
PALI icon
433
Palisade Bio
PALI
$363M
0
AES icon
434
AES
AES
$10.5B
$174K 0.01%
+12,152
New +$171K
TIVO
435
DELISTED
TIVO INC
TIVO
$169K 0.01%
+12,762
New +$164K
HILL
436
DELISTED
DOT HILL SYSTEMS CORP
HILL
$168K 0.01%
+43,350
New +$196K
TBRA
437
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$167K 0.01%
+1,478
New +$104K
XRX icon
438
Xerox
XRX
$424M
$166K 0.01%
+5,563
New +$163K
GFN
439
DELISTED
General Finance Corporation
GFN
$166K 0.01%
+21,000
New +$146K
LEE icon
440
Lee Enterprises
LEE
$181M
$165K 0.01%
+3,688
New +$165K
GTT
441
DELISTED
GTT Communications, Inc.
GTT
$161K 0.01%
+15,250
New +$153K
BIOA
442
DELISTED
BioAmber Inc.
BIOA
$136K 0.01%
+11,900
New +$141K
RFMD
443
DELISTED
RF MICRO DEVICES INC
RFMD
$134K 0.01%
+17,027
New +$105K
QLTY
444
DELISTED
QUALITY DISTR INC FLA
QLTY
$130K 0.01%
+10,000
New +$137K
ATHX
445
DELISTED
Athersys, Inc. Common Stock
ATHX
$121K 0.01%
+1,492
New +$138K
WINT
446
DELISTED
Windtree Therapeutics Inc
WINT
$119K 0.01%
+3,957
New +$133K
LSAK icon
447
Lesaka Technologies
LSAK
$403M
$117K 0.01%
+11,700
New +$109K
LSTA icon
448
Lisata Therapeutics
LSTA
$9.74M
$115K 0.01%
+109
New +$118K
CNVS icon
449
Cineverse
CNVS
$62.3M
$113K 0.01%
+221
New +$119K
DNN icon
450
Denison Mines
DNN
$2.83B
$100K 0.01%
+67,976
New +$95.7K

Similar funds

BlueCrest Capital Management (UK)'s Q1 2014 Portfolio in Review

As of Q1 2014, BlueCrest Capital Management (UK) held 682 positions worth $1.77B, up 46% from $1.22B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

BlueCrest Capital Management (UK) deployed $300M of net new capital in Q1 2014, opening 309 new positions and adding to 98 existing holdings. Its largest new stake was Yellow Corporation Common Stock: 1,242,084 shares worth $27.9M.

By sector, the portfolio is most concentrated in Energy at 14% of assets, up from 9.3% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Medtronic, an estimated $9.5M trimmed.

  • BlueCrest Capital Management (UK)'s largest Q1 2014 buy was Yellow Corporation Common Stock: 1,242,084 shares worth $27.9M.
  • BlueCrest Capital Management (UK) added most to RTX Corp in Q1 2014, an estimated $27.3M increase.
  • BlueCrest Capital Management (UK)'s biggest Q1 2014 reduction was Medtronic, cutting an estimated $9.5M.
  • BlueCrest Capital Management (UK) fully exited State Street SPDR S&P 500 ETF Trust in Q1 2014, selling an estimated $91.8M.
  • BlueCrest Capital Management (UK)'s ten largest holdings make up 28% of its $1.77B portfolio in Q1 2014.
  • BlueCrest Capital Management (UK) opened 309 new positions and closed 186 in Q1 2014.
  • BlueCrest Capital Management (UK)'s portfolio value rose 46% quarter-over-quarter to $1.77B.

Based on BlueCrest Capital Management (UK)'s 13F filing for Q1 2014, filed 15 May 2014.